Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Walmart Partners With Novo Nordisk To Launch US Private-Label Insulin

Company Launches Insulin Aspart And FlexPens As Interchangeable Biosimilars Loom

Executive Summary

Walmart, the famous American multinational retailer, has launched what it is billing as the “first and only” private brand analog insulin, under the company’s brand ReliOn, in partnership with Novo Nordisk. The firm is offering ReliOn NovoLog (insulin aspart) vials and FlexPen in its pharmacies immediately. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB151062

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel